From Blood Transfusions to Gene Therapy: Innovations Driving the India Thalassemia Market to $3.5 Billion by 2035
The management of Thalassemia in India is undergoing a profound transformation, moving from reliance on decades-old supportive care methods to the introduction of revolutionary, curative therapies. Historically, the **India Thalassemia Market** has been defined by two pillars of treatment: regular, life-saving blood transfusions to manage chronic anemia and iron chelation therapy to combat the...
Like
1
0 Commentarios 0 Acciones 38 Views 0 Vista previa